Progress in Cardiovascular Diseases
Volume 45, Issue 2 , Pages 129-138 , September 2002

Eisenmenger's syndrome: Current management

References 

  1. In:  Friedman WF editors. Proceedings of the National Heart, Lung, and Blood Institute Pediatric Cardiology Workshop: Pulmonary hypertension, pediatric research. vol 20:1986;p. 811–824
  2. Eisenmenger V. Die Angeborenen defecte der kammerscheidewand des herzen. Z Klin Med Suppl. 1897;32:1–28
  3. Wood P. The Eisenmenger Syndrome. Br Med J. 1958;2:755
  4. Keck BM, Bennett LE, Rosendale J, et al.  Worldwide thoracic organ transplantation: A report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation. Clin Transpl. 1999;35–49
  5. Hopkins WE, Ochoa LL, Richardson GW, et al.  Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant. 1996;15:100–105
  6. Kidd L, Driscoll DJ, Gersony WM, et al.  Second natural history study of congenital heart efects. Circulation. 1993;87(suppl I):I38–I51
  7. Clarkson PM, Frye RL, DuShane JW, et al.  Prognosis for patients with ventricular septal defect and severe pulmonary vascular obstructive disease. Circulation. 1968;38:129
  8. In:  Rubin LJ,  Rich S editor. Primary Pulmonary Hypertension. Lung Biology in Health and Disease. vol 99:New York: Marcel Dekker; 1977;p. 27–34
  9. Haworth SG. Pulmonary vascular disease in ventricular septal defect: Structural and functional correlations in lung biopsies from 85 patients, with outcome of intracardiac repair. J Pathol. 1987;152:157–168
  10. Fullerton DA, Mitchell MB, Jones DN, et al.  Pulmonary vasomotor dysfunction is produced with chronically high pulmonary blood flow. J Thorac Cardiovasc Surg. 1996;111:190–197
  11. Somerville J. How to manage the Eisenmenger syndrome. Int J Cardiol. 1998;63:1–8
  12. Kerstein D, Levy PS, Hsu DT, et al.  Blade balloon atrial septostomy improves survival in patients with severe primary pulmonary hypertension. Circulation. 1995;91:2028–2035
  13. Sandoval J, Gaspar J, Pulido T, et al.  Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol. 1998;32:297–304
  14. Hausknecht MJ, Sims RE, Nihill MR, et al.  Successful palliation of primary pulmonary hypertension by atrial septostomy. Am J Cardiol. 1990;65:1045–1046
  15. Hopkins WE, Ochou LL, Richardson GW, et al.  Hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant. 1995;14:536
  16. Sandoval J, Rothman A, Pulido T. Atrial septostomy for pulmonary hypertension. Clin Chest Med. 2001;22:547–560
  17. Barst RJ. Recent advances in the treatment of pediatric pulmonary artery hypertension. Pediatric Clin North Am. 1999;46:2
  18. Boyer JJ, Busst CM, Denison DM, et al.  Effect of long-term oxygen treatment at home in children with pulmonary vascular disease. Br Heart J. 1985;55:385–390
  19. Rich S, Seidlitz M, Dodin E, et al.  The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest. 1998;114:787–792
  20. Rosove MH, Perloff JK, Hocking WG, et al.  Chronic hypoxaemia and decompensated erythrocytosis in cyanotic congenital heart disease. Lancet. 1986;2:313
  21. Perloff JK. Systemic complications of cyanosis in adults with congenital heart disease: Hematologic derangements, renal function, and urate metabolism. Cardiol Clin. 1993;11:689–699
  22. Berman-Rosenzweig E, Kerstein D, Barst RJ. Chronic prostacyclin therapy for pulmonary hypertension with associated congenital heart defects. Circulation. 1999;99:1858–1865
  23. Rich S, Kaufmann E, Levy P. The effects of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992;327:76–81
  24. Berman-Rosenzweig E, Maislin G, Kerstein D, et al.  Acute vasodilator response and survival in patients with pulmonary vascular disease and congenital heart defects. Am J Respir Crit Care Med. 2000;161:A423
  25. Rosovec A, Montanes P, Oakley C. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J. 1986;55:449–458
  26. Young D, Mark H. Fate of the patient with Eisenmenger's syndrome. Am J Cardiol. 1971;28:658–669
  27. Trulock EP. Lung transplantation for primary pulmonary hypertension. Clin Chest Med. 2001;22:583–593
  28. Pasque MK, Trulock EP, Cooper JD, et al.  Single lung transplantation for pulmonary hypertension: Single institution experience in 34 patients. Circulation. 1995;92:2252–2258
  29. Gurtner HP. Pulmonary hypertension, plexogenic pulmonary arteriopathy and the appetite depressant drug aminorex: Post or propter?. Bull Eur Physiopathol Respir. 1979;15:897–923
  30. Greiser E. Epidemiologische untersuchungen zum zusammenhang zwischen appetitzueglere innahme und primaer vasculaer pulmonaler hypertonie. Internist. 1973;14:437–442
  31. Douglas JG, Munro JF, Kitchin AH, et al.  Pulmonary hypertension and fenfluramine. Br Med J. 1981;283:881–883
  32. Roche N, Labrune S, Braun JM, et al.  Pulmonary hypertension and dexfenfluramine. Lancet. 1992;339:436–437 (letter)
  33. Brenot F, Herve P, Petitpretz P, et al.  Primary pulmonary hypertension and fenfluramine use. Br Heart J. 1993;70:537–541
  34. Deng Z, Morse JH, Slager SL, et al.  Familial primary pulmonary hypertension (gene PPH 1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet. 2000;67:737–744
  35. Nichols WC, Koller DL, Slovis B, et al.  Localization of the gene for familial PPH to chromosome 2q31-32. Nat Genet. 1997;15:277–280
  36. Morse JH, Jones AC, Barst RJ, et al.  Mapping of familial primary pulmonary hypertension locus (PPH 1) to chromosome 2q31-32. Circulation. 1997;95:2603–2606

☆ Address reprint requests to Erika Berman Rosenzweig, MD, Division of Pediatric Cardiology, Children's Hospital of New York, New-York Presbyterian, 3959 Broadway, 2 North, New York, NY 10032; esb14@columbia.edu.

PII: S0033-0620(02)70003-0

doi: 10.1053/pcad.2002.127492

Progress in Cardiovascular Diseases
Volume 45, Issue 2 , Pages 129-138 , September 2002

Article Tools

* Image Usage & Resolution